sulfinpyrazone has been researched along with Primary Myelofibrosis in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Primary Myelofibrosis: A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SMYTHE, HA | 1 |
| OGRYZLO, MA | 1 |
| MURPHY, EA | 1 |
| MUSTARD, JF | 1 |
1 other study available for sulfinpyrazone and Primary Myelofibrosis
| Article | Year |
|---|---|
THE EFFECT OF SULFINPYRAZONE (ANTURAN) ON PLATELET ECONOMY AND BLOOD COAGULATION IN MAN.
Topics: Arthritis; Arthritis, Rheumatoid; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Drug | 1965 |